Telomir Pharmaceuticals

(NASDAQ) TELO

Current Price$1.40

Market Cap$48.13M

Since IPO (2024)-72%

5 YearN/A

1 Year-44%

1 Month+6%

Telomir Pharmaceuticals Financials at a Glance

Market Cap

$48.13M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.41M

EPS (TTM)

$-0.34

P/E Ratio

-4.17

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.40

Volume

550

Open

$1.37

Price

$1.40

Volume

550

Open

$1.37

Previous Close

$1.40

Daily Range

$1.37 - $1.41

52-Week Range

$1.05 - $3.10

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.40

Volume

550

Open

$1.37

Previous Close

$1.40

Daily Range

$1.37 - $1.41

52-Week Range

$1.05 - $3.10

TELO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Telomir Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Erez Aminov

Website

www.telomirpharma.com

Headquarters

Baltimore, FL 21205, US

TELO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-318%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-23.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$48.13M

Shares Outstanding

34.38M

Volume

550

Avg. Volume

138.80K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$10.54M

EBITDA

$10.54M

Operating Cash Flow

$3.69M

Capital Expenditure

$0.00

Free Cash Flow

$3.69M

Cash & ST Invst.

$7.29M

Total Debt

$0.00

Telomir Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$48.13M

N/A

Market Cap/Employee

$48.13M

N/A

Employees

N/A

Net Income

$2.06M

+28.9%

EBITDA

$2.13M

+26.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$7.29M

+521.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.42%

N/A

Return on Invested Capital

-1.78%

N/A

Free Cash Flow

$1.20M

-98.3%

Operating Cash Flow

$1.20M

-98.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.51+5.59%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.$0.82-6.29%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.65+0.11%

EQEquillium, Inc.

EQEquillium, Inc.$2.08+1.96%

KPTIKaryopharm Therapeutics Inc.

KPTIKaryopharm Therapeutics Inc.$8.77+5.54%

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$0.73+2.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

MARAMara Holdings

MARAMara Holdings$11.46-0.04%

Questions About TELO

What is the current price of Telomir Pharmaceuticals?

Telomir Pharmaceuticals is trading at $1.40 per share.

What is the 52-week range for Telomir Pharmaceuticals?

Over the past 52 weeks, Telomir Pharmaceuticals has traded between $1.05 and $3.10.

How much debt does Telomir Pharmaceuticals have?

As of the most recent reporting period, Telomir Pharmaceuticals reported total debt of N/A.

How much cash does Telomir Pharmaceuticals have on hand?

Telomir Pharmaceuticals reported $7.29M in cash and cash equivalents in its most recent financial results.

What is Telomir Pharmaceuticals’s dividend yield?

Telomir Pharmaceuticals does not currently have a dividend yield.

Telomir Pharmaceuticals

Telomir Pharmaceuticals Financials at a Glance

TELO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Telomir Pharmaceuticals

TELO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Telomir Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TELO

What is the current price of Telomir Pharmaceuticals?

What is the 52-week range for Telomir Pharmaceuticals?

How much debt does Telomir Pharmaceuticals have?

How much cash does Telomir Pharmaceuticals have on hand?

What is Telomir Pharmaceuticals’s dividend yield?

Premium Investing Services